Profile data is unavailable for this security.
About the company
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. The Company is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). It is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include Ropidoxuridine (IPdR), Ropidoxuridine and Tipracil (IPdR/TPI), SP-1-161, SP-2-225, and SP-1-303. Ropidoxuridine (IPdR) is its lead candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. Ropidoxuridine and Tipracil (IPdR/TPI) is undergoing preclinical development for use as a radiation sensitizer for rectal cancers. SP-1-161 is a pre-clinical candidate lead histone deacetylase (HDAC) inhibitor, a radiation sensitizing candidate product. SP-2-225 is a pre-clinical class II b selective HDAC inhibitor that affects histone deacetylase HDAC6.
- Revenue in USD (TTM)0.00
- Net income in USD-7.35m
- Incorporated2018
- Employees8.00
- LocationShuttle Pharmaceuticals Holdings Inc401 Professional Drive, Suite 260GAITHERSBURG 20879United StatesUSA
- Phone+1 (240) 403-4212
- Fax+1 (845) 818-3588
- Websitehttps://shuttlepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endexx Corp | 4.64m | 6.93m | 8.15m | -- | 1.21 | -- | 1.37 | 1.76 | 0.0133 | 0.0133 | 0.0091 | -0.0255 | 0.6773 | 4.37 | 13.54 | -- | 86.51 | -- | -- | -- | 28.73 | -- | 127.74 | -- | 0.0664 | -- | -- | -- | 228.66 | -- | 28.26 | -- | -- | -- |
| Odonate Inc | 0.00 | -102.07m | 8.33m | 137.00 | -- | 307.35 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| BioCardia Inc | 468.00k | -10.34m | 8.41m | 16.00 | -- | -- | -- | 17.97 | -0.4692 | -0.4692 | 0.0209 | -0.0848 | 0.0954 | -- | 4.44 | 29,250.00 | -210.81 | -107.34 | -1,190.90 | -154.17 | -- | -- | -2,208.76 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| BioRestorative Therapies Inc | 145.80k | -14.42m | 8.46m | 11.00 | -- | 0.5101 | -- | 58.04 | -3.54 | -3.54 | 0.0346 | 2.45 | 0.01 | -- | 8.26 | 13,254.55 | -99.26 | -199.86 | -104.68 | -334.04 | -- | -- | -9,887.16 | -19,887.03 | -- | -- | 0.00 | -- | 21.70 | 5.61 | 22.06 | -- | 67.77 | -- |
| Viaderma Inc | 17.80m | 2.31m | 8.51m | 75.00 | 0.0004 | 0.00003 | 1.57 | 0.4782 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
| Energy Finders Inc | 4.06m | -2.92m | 8.61m | 46.00 | -- | -- | -- | 2.12 | -0.272 | -0.272 | 1.52 | 3.04 | -- | -- | -- | 88,304.35 | -- | -- | -- | -- | 27.45 | -- | -71.79 | -- | 0.6706 | -12.57 | 0.564 | -- | -- | -- | -- | -- | -- | -- |
| ABVC Biopharma Inc | 25.37k | -12.62m | 8.62m | 16.00 | -- | 1.09 | -- | 339.67 | -2.37 | -2.37 | 0.0043 | 0.7284 | 0.002 | -- | 0.0673 | 1,585.63 | -103.15 | -103.38 | -189.31 | -231.54 | -854.20 | 76.25 | -51,218.29 | -2,019.89 | -- | -3.19 | 0.1853 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
| Weed Inc | 0.00 | -5.19k | 8.70m | 2.00 | -- | 80.95 | 222.15 | -- | -0.00001 | -0.00001 | 0.00 | 0.0009 | 0.00 | -- | -- | 0.00 | -0.4942 | -385.93 | -9.56 | -822.37 | -- | -- | -- | -- | -- | -23.03 | 0.5461 | -- | -- | -- | 97.93 | -- | -59.13 | -- |
| Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.35m | 8.92m | 8.00 | -- | 3.23 | -- | -- | -0.4739 | -0.4739 | 0.00 | 0.1642 | 0.00 | -- | -- | 0.00 | -96.75 | -- | -119.37 | -- | -- | -- | -- | -- | -- | -5.28 | 0.2542 | -- | -- | -- | -112.71 | -- | -- | -- |
| Notable Labs Ltd | 311.00k | -12.39m | 9.02m | 16.00 | -- | 0.7811 | -- | 29.00 | -2.31 | -2.31 | 0.0622 | 1.28 | 0.0142 | -- | -- | 19,437.50 | -56.70 | -52.02 | -74.10 | -62.09 | 37.30 | 60.19 | -3,984.24 | -3,636.93 | -- | -- | 0.0271 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
| Oragenics Inc | 20.63k | -20.26m | 9.05m | 5.00 | -- | 8.77 | -- | 438.73 | -7.98 | -7.98 | 0.0079 | 0.5859 | 0.0026 | -- | -- | 4,126.00 | -258.71 | -97.60 | -312.34 | -106.24 | -- | -- | -98,214.93 | -36,169.75 | -- | -- | 0.0461 | -- | -71.37 | -- | -44.56 | -- | 51.64 | -- |
| Cannapharmarx Inc | 0.00 | 3.69m | 9.14m | 21.00 | 1.71 | -- | 2.40 | -- | 0.0081 | 0.0081 | 0.00 | -0.028 | 0.00 | -- | -- | 0.00 | 42.99 | -131.06 | -- | -- | -- | -- | -- | -- | 0.0034 | -1.02 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Pacific Software Inc | 0.00 | -77.46k | 9.36m | 0.00 | -- | 0.3008 | -- | -- | -0.1832 | -0.1832 | 0.00 | 0.7646 | 0.00 | -- | -- | -- | -26.19 | -620.48 | -66.38 | -- | -- | -- | -- | -- | -- | -6.29 | 0.00 | -- | -- | -- | -13.29 | -- | -- | -- |
| Portage Biotech Inc | 0.00 | -144.90m | 9.47m | 7.00 | -- | 0.296 | -- | -- | -7.96 | -7.96 | 0.00 | 1.62 | 0.00 | -- | -- | 0.00 | -111.60 | -19.70 | -113.27 | -26.48 | -- | -- | -- | -- | -- | -- | 0.0087 | -- | -- | -- | -520.10 | -- | -- | -- |
| Enzon Pharmaceuticals Inc | 0.00 | 221.00k | 9.65m | 0.00 | 43.62 | 2.93 | -- | -- | 0.003 | 0.003 | 0.00 | 0.624 | 0.00 | -- | -- | -- | 3.21 | -0.8654 | 3.24 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
| Calidi Biotherapeutics Inc | 0.00 | -29.98m | 9.68m | 41.00 | -- | -- | -- | -- | -0.6765 | -0.6765 | 0.00 | -0.4079 | 0.00 | -- | -- | 0.00 | -382.78 | -- | -- | -- | -- | -- | -- | -- | -- | -27.45 | -- | -- | -100.00 | -- | -14.90 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Shuttle Pharmaceuticals Holdings Inc's reporting currency: US Dollar USD
1.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ayrton Capital LLCas of 30 Sep 2023 | 220.43k | 1.31% |
| Geode Capital Management LLCas of 31 Mar 2024 | 36.96k | 0.22% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 16.50k | 0.10% |
| Virtu Americas LLCas of 31 Mar 2024 | 10.48k | 0.06% |
| UBS Securities LLCas of 31 Mar 2024 | 1.12k | 0.01% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 500.00 | 0.00% |
| Tower Research Capital LLCas of 31 Mar 2024 | 251.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 54.00 | 0.00% |
| StoneX Group, Inc. (Investment Management)as of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
